9.9% YoY and 2.6% QoQ to stand at Bt6,968mn. EBITDA stood at Bt18,071mn, decreasing 2. 1% YoY but increasing 1. 4% QoQ, a 42. 6% EBITDA margin ( excluding equipment rental) . Depreciation and

plan regarding the expansion of biodiesel business of the Company. Details of the Board of Directors’ opinion and details of the capital increase and the allocation of the newly issued ordinary shares

focused on continuous expansion of dialysis unit. On the past 29 th September, 2017 the subsidiary additionally purchased assets from business of a dialysis unit which is business expansion as a plan laid

decreasing in total revenue from sales. The consolidated gross profit margin contributed of 14.30% in 2Q2020, slightly increased from 13.87% in 2Q2019. The participating profit from associates was THB 84.96

. The decreasing revenue derived from sale and services by THB 230 million or 11% and THB 969 million or 60% respectively. A decrease in total revenues was mainly derived from services income from beauty

decreasing revenue derived from sale and services by THB 230 million or 11% and THB 969 million or 60% respectively. A decrease in total revenues was mainly derived from services income from beauty services

revenue streams to mitigate the risk of reliance on sales in China. Currently, the Company received good feedbacks from the market expansion in the Philippines but still could not compensate for the

new projects that will be launched in 2019. Moreover, there are on-going negotiation with new partners for expansion of commercial building business. This could add up recurring revenue in the Company’s

per annum. However such issuance and offering of debenture caused from the objective to prepare the source of fund for the business expansion in the future. 3. Profit for the period Unit: Million Baht

% Cost of sales and service decrease 6.5% QoQ from Baht 1,274.4 million to Baht 1,191.7 million. The decreasing of Baht 82.7 million mainly derived from decrease in cost of natural gas power plant when